查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702113

前列腺癌治療市場報告（按藥物類型（化療、生物療法、荷爾蒙療法等）、配銷通路（醫院藥房、藥房和零售藥房、線上藥房）和地區）2025 年至 2033 年

Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024年全球前列腺癌治療市場規模達81億美元。展望未來， IMARC Group預計到2033年市場規模將達到124億美元，2025-2033年期間的成長率（CAGR）為4.9%。前列腺疾病盛行率的不斷上升、個人化醫療的進步、新療法的出現、醫療保健支出的增加以及公眾對前列腺健康和可用治療方案的認知的不斷提高，都在促進市場的成長。

前列腺癌是一種嚴重的惡性腫瘤，是由男性前列腺內各種異常細胞不受控制地分裂、增殖引起的。可以透過使用各種療法來治療，例如疫苗、藥物和治療。其中，化療、免疫療法、冷凍療法、手術、荷爾蒙療法、標靶療法和放射療法是一些最常見的治療類型，有助於減輕體內癌細胞的擴散。這些療法是根據各種評估結果提供給患者的，例如患者的年齡、所經歷症狀的嚴重程度、醫療狀況和既往健康史。

前列腺癌治療市場趨勢：

攝護腺癌盛行率的不斷上升，尤其是在老年人口不斷增加的情況下，是目前推動市場成長的主要因素之一。同時，優惠的醫療報銷政策以及多個國家的政府機構為引入患者援助計劃（PAP）而採取的眾多舉措也成為其他成長推動因素。 PAP 是一個有組織的項目，由製藥公司控制，透過提供免費藥物用於治療來為患者提供經濟援助。此外，重大技術進步也促進了市場成長，例如將多參數磁振造影 (mp-MRI) 設備與非轉移性去勢抗性 (nmCRPC) 和轉移性荷爾蒙陰性 (mHNPC) 設定相結合，用於在早期檢測前列腺癌，同時減少診斷錯誤。此外，對研發 (R&D) 活動的大量投資以推出新型治療產品，以及這些產品在各種線上和線下分銷管道上的便捷供應，為市場創造了積極的前景。

本報告回答的關鍵問題

  • 2024 年全球前列腺癌治療市場規模？ 2025 年至 2033 年期間全球前列腺癌治療市場的預期成長率為何？
  • 推動全球前列腺癌治療市場發展的關鍵因素有哪些？
  • COVID-19 對全球前列腺癌治療市場有何影響？
  • 根據藥物類型，全球前列腺癌治療市場是如何分佈的？
  • 根據配銷通路，全球前列腺癌治療市場如何分佈？
  • 全球前列腺癌治療市場的關鍵區域有哪些？
  • 全球前列腺癌治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球前列腺癌治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依藥物類型

  • 化療
  • 生物治療
  • 荷爾蒙療法
  • 其他

第7章：市場區隔：按配銷通路

  • 醫院藥房
  • 藥局和零售藥房
  • 網路藥局

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • GlaxoSmithKline Plc
    • Ipsen (Mayroy SA)
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
Product Code: SR112025A6185

The global prostate cancer treatment market size reached USD 8.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing prevalence of the disease, advancements in personalized medicine, the emergence of new therapies, higher healthcare spending, and growing public awareness about prostate health and available treatment options are strengthening the market growth.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global prostate cancer treatment market in 2024?
  • 2.What is the expected growth rate of the global prostate cancer treatment market during 2025-2033?
  • 3.What are the key factors driving the global prostate cancer treatment market?
  • 4.What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5.What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7.What are the key regions in the global prostate cancer treatment market?
  • 8.Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2024
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players